Assessing the Usefulness of the Prevexair Smartphone Applicationin the Follow-Up High-Risk Patients with COPD
Loading...
Official URL
Full text at PDC
Publication date
2021
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Dovepress
Citation
Rodríguez Hermosa, J. L., Fuster Gomila, A., Puente Maestu, L., Amado Diago, C. A., Callejas-González, F. J., Malo De Molina Ruiz, R., Fuentes Ferrer, M. E., Alvarez-Sala, J. L., & Calle Rubio, M. (2021). Assessing the usefulness of the prevexair smartphone application in the follow-up high-risk patients with copd. International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 53-65. https://doi.org/10.2147/COPD.S279394
Abstract
Introduction: This manuscript analyzes the exacerbations recorded by the Prevexair
application through the daily analysis of symptoms in high-risk patients with COPD
and explores its usefulness in assessing clinical stability with respect to that reported in
visits.
Patients and Methods: This study is a multi-centre cohort of COPD patients with the
exacerbator phenotype who were monitored over 6 months. The Prevexair application was
installed on the patients’ smartphones. Patients used the app to record symptom changes, use
of medication and use of healthcare resources. It is not established a recommended action
plan when worsening of symptoms. At their clinical visit during the follow-up period,
patients were asked about exacerbations suffered during these 6 months of monitoring.
The investigators who conducted the visit were blinded about the Prevexair app records.
Results: The patients experienced a total of 185 exacerbations according to daily records in
the app whereas only 64 exacerbations were recalled during medical visits. Perception
became more accurate for severe exacerbations (kappa 0.6577), although we found no factors
that predicted poor recall. The proportion of 72.5% patients were classified as unstable if the
exacerbations captured by Prevexair were used to define stability, versus 47.8% if the
exacerbations recall in visit was used. Two-thirds of the exacerbations recorded in the
Prevexair application were not reported to doctors during their clinical visits. Almost half
were treated with oral corticosteroids and/or antibiotics and more than one-quarter of the
exacerbations treated did not seek medical attention.
Conclusion: The findings of this cohort study confirm that patients do not always remember
the exacerbations suffered during their medical visit. The prevexair application is useful in
monitoring COPD patients at high risk, in order to a better assessment of exacerbations of
COPD during medical visits. Further research must be carried out to evaluate this strategy in
clinical practice.
Keywords: chronic obstructive pulmonary disease, telemonitoring, mobile health,
exacerbations, clinical prediction, management, electronic patient record











